In mouse models of type 2 diabetes induced by a highfat diet and streptozotocin, 4 weeks of 5amino1mq injection reduced fasting blood glucose by 25%30%, increased insulin secretion by over 20%, and significantly decreased cell apoptosis
Studies suggest appetite reduction may begin within a few weeks of starting GLP-1 medications, while meaningful changes in weight metrics may appear after 820 weeks, with continued improvement over 6 months or more
In other words, once we improve glycaemic levels, GIP doesnt increase glucagon secretion
doi: 10.1016/j.bbamcr.2019.118535 36 TurcuALVersiniAKheneNGailletCCanequeTMullerSet al
Heavy alcohol use is a major cofactor that significantly raises the risk of HCC in patients with HBV-related cirrhosis
Because NNMT activity in fat cells has been linked to obesity